Inventor · Pollionnay, FR

Jean Haensler

19Patents
9h-index
31Co-inventors
72Inventor score

Filing activity: Jun 6, 1995 → Oct 15, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US5661025A Self-assembling polynucleotide delivery system comprising dendrimer polycations Chemistry; Metallurgy 108 Expired
US6113946A Self-assembling polynucleotide delivery system comprising dendrimer polycations Chemistry; Metallurgy 47 Expired
US6300317A Self-assembling polynucleotide delivery system Chemistry; Metallurgy 41 Expired
US5977084A Self-assembling polynucleotide delivery method Chemistry; Metallurgy 37 Expired
US6780421B1 Adjuvant for a vaccine composition Chemistry; Metallurgy 36 Expired
US6610308B1 Immunostimulant emulsion Human Necessities 34 Expired
US6126938A Methods for inducing a mucosal immune response Emerging Cross-Sectional Technologies 33 Expired
US6124270A Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug Emerging Cross-Sectional Technologies 22 Expired
US5955365A Self-assembling polynucleotide delivery system Chemistry; Metallurgy 21 Expired
US7344720B2 Vaccine composition Emerging Cross-Sectional Technologies 7 Expired
US5990089A Self-assembling polynucleotide delivery system comprising dendrimer polycations Chemistry; Metallurgy 5 Expired
US9504659B2 Thermoreversible oil-in-water emulsion Chemistry; Metallurgy 4 Active
US9327021B2 Immunogenic compositions Human Necessities 3 Active
US9770505B2 Vaccine composition with aluminium hydroxide nanoparticles Emerging Cross-Sectional Technologies 1 Active
US11554170B2 Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants Emerging Cross-Sectional Technologies 0 Active
US11524069B2 Human cytomegalovirus immunogenic composition Chemistry; Metallurgy 0 Active
US11207403B2 Human cytomegalovirus immunogenic composition Chemistry; Metallurgy 0 Active
US8506971B2 Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria Human Necessities 0 Active
US7767658B2 Vaccine composition Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.